Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.

George J, Tsutsumi M, Tsuchishima M.

J Cell Mol Med. 2017 Dec;21(12):3821-3835. doi: 10.1111/jcmm.13304. Epub 2017 Aug 7.

2.
3.

Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.

Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, Gaudio E.

Liver Int. 2009 Aug;29(7):997-1009. doi: 10.1111/j.1478-3231.2009.02011.x. Epub 2009 Apr 28.

PMID:
19422482
4.

Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.

Cheng Q, Li C, Yang CF, Zhong YJ, Wu D, Shi L, Chen L, Li YW, Li L.

Chem Biol Interact. 2019 Feb 1;299:131-139. doi: 10.1016/j.cbi.2018.12.006. Epub 2018 Dec 11.

PMID:
30543783
5.

Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.

Liang B, Guo XL, Jin J, Ma YC, Feng ZQ.

World J Gastroenterol. 2015 May 7;21(17):5271-80. doi: 10.3748/wjg.v21.i17.5271.

6.

Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.

Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu Y, Sun M, Chen G, Zhang H, Liu P.

J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.

PMID:
27282665
7.

Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis.

Li C, Jiang W, Zhu H, Hou J.

Pharm Biol. 2012 Apr;50(4):413-9. doi: 10.3109/13880209.2011.608193. Epub 2011 Dec 1. Retraction in: Pezzuto JM, Patel P. Pharm Biol. 2013 May;51(5):675.

PMID:
22129045
8.

Interleukin-1 participates in the progression from liver injury to fibrosis.

Gieling RG, Wallace K, Han YP.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1324-31. doi: 10.1152/ajpgi.90564.2008. Epub 2009 Apr 2.

9.

Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage.

Arauz J, Moreno MG, Cortés-Reynosa P, Salazar EP, Muriel P.

J Appl Toxicol. 2013 Sep;33(9):970-9. doi: 10.1002/jat.2788. Epub 2012 Aug 17.

PMID:
22899499
10.

Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.

Zhou B, Ling L, Zhang F, Liu TY, Zhou H, Qi XH, Chen Q, Li YH, Kang YM, Zhu GQ.

Cell Physiol Biochem. 2018;48(1):227-236. doi: 10.1159/000491722. Epub 2018 Jul 13.

11.

Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.

Chen L, Charrier AL, Leask A, French SW, Brigstock DR.

J Hepatol. 2011 Aug;55(2):399-406. doi: 10.1016/j.jhep.2010.11.025. Epub 2010 Dec 13.

12.

Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.

Zhang YQ, Wan LY, He XM, Ni YR, Wang C, Liu CB, Wu JF.

DNA Cell Biol. 2017 Jul;36(7):603-610. doi: 10.1089/dna.2017.3707. Epub 2017 May 3.

PMID:
28467108
13.

Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.

Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.

Scand J Gastroenterol. 2009;44(3):358-65. doi: 10.1080/00365520802530861.

PMID:
18991162
14.

[Effect of interferon-α on rat liver fibrosis induced by CCl(4)].

Li Y, Yang H.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Mar;36(3):243-8. doi: 10.3969/j.issn.1672-7347.2011.03.009. Chinese.

15.

Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice.

Huang G, Besner GE, Brigstock DR.

Lab Invest. 2012 May;92(5):703-12. doi: 10.1038/labinvest.2012.3. Epub 2012 Feb 13.

16.

Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats.

Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, Zhou H, Lu H, Jin Y.

J Gene Med. 2006 Jul;8(7):889-900.

PMID:
16652398
17.

HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1.

Shin JY, Hur W, Wang JS, Jang JW, Kim CW, Bae SH, Jang SK, Yang SH, Sung YC, Kwon OJ, Yoon SK.

Exp Mol Med. 2005 Apr 30;37(2):138-45.

PMID:
15886528
18.

Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.

França MER, Rocha SWS, Oliveira WH, Santos LA, de Oliveira AGV, Barbosa KPS, Nunes AKS, Rodrigues GB, Lós DB, Peixoto CA.

Inflammopharmacology. 2018 Apr;26(2):599-609. doi: 10.1007/s10787-017-0329-0. Epub 2017 Apr 13.

PMID:
28409388
19.

l-Theanine prevents carbon tetrachloride-induced liver fibrosis via inhibition of nuclear factor κB and down-regulation of transforming growth factor β and connective tissue growth factor.

Pérez-Vargas JE, Zarco N, Vergara P, Shibayama M, Segovia J, Tsutsumi V, Muriel P.

Hum Exp Toxicol. 2016 Feb;35(2):135-46. doi: 10.1177/0960327115578864. Epub 2015 Apr 7.

PMID:
25852135
20.

Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.

Marquez-Aguirre A, Sandoval-Rodriguez A, Gonzalez-Cuevas J, Bueno-Topete M, Navarro-Partida J, Arellano-Olivera I, Lucano-Landeros S, Armendariz-Borunda J.

J Gene Med. 2009 Mar;11(3):207-19. doi: 10.1002/jgm.1303.

PMID:
19189315

Supplemental Content

Support Center